1lt9: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
We report two crystal structures, each at a resolution of 2.8 A, of, recombinant human fibrinogen fragment D (rfD) in the absence and presence, of peptide ligands. The bound ligands, Gly-Pro-Arg-Pro-amide and, Gly-His-Arg-Pro-amide, mimic the interactions of the thrombin exposed, polymerization sites, "A" and "B", respectively. This report is the first, to describe the structure of fragment D in the presence of both peptide, ligands. The structures reveal that recombinant fibrinogen is nearly, identical to the plasma protein but with minor changes, like the addition, of a proximal fucose to the carbohydrate linked to residue betaGln364, and, slightly different relative positions of the beta- and gamma-modules. Of, major interest in our structures is that a previously identified calcium, site in plasma fibrinogen is absent when Gly-His-Arg-Pro-amide is bound., The peptide-dependent loss of this calcium site may have significant, biological implications that are further discussed. These structures, provide a foundation for the detailed structural analysis of variant, recombinant fibrinogens that were used to identify critical functional, residues within fragment D.
We report two crystal structures, each at a resolution of 2.8 A, of recombinant human fibrinogen fragment D (rfD) in the absence and presence of peptide ligands. The bound ligands, Gly-Pro-Arg-Pro-amide and Gly-His-Arg-Pro-amide, mimic the interactions of the thrombin exposed polymerization sites, "A" and "B", respectively. This report is the first to describe the structure of fragment D in the presence of both peptide ligands. The structures reveal that recombinant fibrinogen is nearly identical to the plasma protein but with minor changes, like the addition of a proximal fucose to the carbohydrate linked to residue betaGln364, and slightly different relative positions of the beta- and gamma-modules. Of major interest in our structures is that a previously identified calcium site in plasma fibrinogen is absent when Gly-His-Arg-Pro-amide is bound. The peptide-dependent loss of this calcium site may have significant biological implications that are further discussed. These structures provide a foundation for the detailed structural analysis of variant recombinant fibrinogens that were used to identify critical functional residues within fragment D.


==Disease==
==Disease==
Line 17: Line 17:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Betts, L.]]
[[Category: Betts, L.]]
[[Category: Gorkun, O.V.]]
[[Category: Gorkun, O V.]]
[[Category: Kostelansky, M.S.]]
[[Category: Kostelansky, M S.]]
[[Category: Lord, S.T.]]
[[Category: Lord, S T.]]
[[Category: CA]]
[[Category: CA]]
[[Category: NAG]]
[[Category: NAG]]
Line 28: Line 28:
[[Category: recombinant fibrinogen fragment d]]
[[Category: recombinant fibrinogen fragment d]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:20:17 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:48:15 2008''

Revision as of 14:48, 21 February 2008

File:1lt9.jpg


1lt9, resolution 2.80Å

Drag the structure with the mouse to rotate

Crystal Structure of Recombinant Human Fibrinogen Fragment D

OverviewOverview

We report two crystal structures, each at a resolution of 2.8 A, of recombinant human fibrinogen fragment D (rfD) in the absence and presence of peptide ligands. The bound ligands, Gly-Pro-Arg-Pro-amide and Gly-His-Arg-Pro-amide, mimic the interactions of the thrombin exposed polymerization sites, "A" and "B", respectively. This report is the first to describe the structure of fragment D in the presence of both peptide ligands. The structures reveal that recombinant fibrinogen is nearly identical to the plasma protein but with minor changes, like the addition of a proximal fucose to the carbohydrate linked to residue betaGln364, and slightly different relative positions of the beta- and gamma-modules. Of major interest in our structures is that a previously identified calcium site in plasma fibrinogen is absent when Gly-His-Arg-Pro-amide is bound. The peptide-dependent loss of this calcium site may have significant biological implications that are further discussed. These structures provide a foundation for the detailed structural analysis of variant recombinant fibrinogens that were used to identify critical functional residues within fragment D.

DiseaseDisease

Known diseases associated with this structure: Afibrinogenemia, congenital OMIM:[134820], Afibrinogenemia, congenital OMIM:[134830], Amyloidosis, hereditary renal OMIM:[134820], Dysfibrinogenemia, alpha type, causing bleeding diathesis OMIM:[134820], Dysfibrinogenemia, alpha type, causing recurrent thrombosis OMIM:[134820], Dysfibrinogenemia, beta type OMIM:[134830], Dysfibrinogenemia, gamma type OMIM:[134850], Hypofibrinogenemia, gamma type OMIM:[134850], Thrombophilia, dysfibrinogenemic OMIM:[134830], Thrombophilia, dysfibrinogenemic OMIM:[134850]

About this StructureAbout this Structure

1LT9 is a Protein complex structure of sequences from Homo sapiens with and as ligands. Full crystallographic information is available from OCA.

ReferenceReference

2.8 A crystal structures of recombinant fibrinogen fragment D with and without two peptide ligands: GHRP binding to the "b" site disrupts its nearby calcium-binding site., Kostelansky MS, Betts L, Gorkun OV, Lord ST, Biochemistry. 2002 Oct 8;41(40):12124-32. PMID:12356313

Page seeded by OCA on Thu Feb 21 13:48:15 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA